Ventilator-associated pneumonia among elderly Medicare beneficiaries in long-term care hospitals
- PMID: 20191753
- PMCID: PMC4195065
Ventilator-associated pneumonia among elderly Medicare beneficiaries in long-term care hospitals
Abstract
Ventilator-associated pneumonia (VAP) is a complication of ventilator care that produces excess, avoidable resource use and treatment costs. Control of VAP is an important aspect of quality of care improvement for long-term care hospitals (LTCHs) since they provide post-acute ventilator care for many Medicare beneficiaries. Data for Medicare patients discharged from LTCHs during CY 2004 who received continuous mechanical ventilation are examined (N=13,759). Nearly 25% of Medicare LTCH ventilator patients acquired VARP Despite having lower mortality and less co-morbidity than non-VAP patients, length of stay (LOS) and total charges were both higher for VAP patients. Some of this excess is avoidable.
Figures
References
-
- Bregeon F, Ciais V, Carret V, et al. Is Ventilator-associated Pneumonia an Independent Risk Factor for Death? Anesthesiology. 2001;94(4):551–553. - PubMed
-
- Chenoweth C, Washer L, Obeyesekera K, et al. Ventilator-associated Pneumonia in the Home Care Setting. Infection Control in Hospital Epidemiology. 2007;28(8):910–915. - PubMed
-
- Chastre J, Fagon JY. Ventilator-associated Pneumonia. American Journal of Respiratory and Critical Care Medicine. 2002;165:867–903. - PubMed
-
- Dries D, McGonigal M, Malian M, et al. Protocol-driven Ventilator Weaning Reduces Use of Mechanical Ventilation, Rate of Early Intubation and Ventilator-associated Pneumonia. Journal of Trauma. 2005;56(5):943–951. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical